185 related articles for article (PubMed ID: 29597130)
21. Correlations of microRNA:microRNA expression patterns reveal insights into microRNA clusters and global microRNA expression patterns.
Chaulk SG; Ebhardt HA; Fahlman RP
Mol Biosyst; 2016 Jan; 12(1):110-9. PubMed ID: 26563430
[TBL] [Abstract][Full Text] [Related]
22. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels.
Wu X; Zeng R; Wu S; Zhong J; Yang L; Xu J
Gene; 2015 Feb; 557(2):195-200. PubMed ID: 25523096
[TBL] [Abstract][Full Text] [Related]
24. Global analysis of miRNA gene clusters and gene families reveals dynamic and coordinated expression.
Guo L; Yang S; Zhao Y; Zhang H; Wu Q; Chen F
Biomed Res Int; 2014; 2014():782490. PubMed ID: 24791000
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
26. Multifaceted enrichment analysis of RNA-RNA crosstalk reveals cooperating micro-societies in human colorectal cancer.
Mazza T; Mazzoccoli G; Fusilli C; Capocefalo D; Panza A; Biagini T; Castellana S; Gentile A; De Cata A; Palumbo O; Stallone R; Rubino R; Carella M; Piepoli A
Nucleic Acids Res; 2016 May; 44(9):4025-36. PubMed ID: 27067546
[TBL] [Abstract][Full Text] [Related]
27. Analysis of miRNA expression profiles in breast cancer using biclustering.
Fiannaca A; La Rosa M; La Paglia L; Rizzo R; Urso A
BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S7. PubMed ID: 25734576
[TBL] [Abstract][Full Text] [Related]
28. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
29. Network analysis of EMT and MET micro-RNA regulation in breast cancer.
Drago-García D; Espinal-Enríquez J; Hernández-Lemus E
Sci Rep; 2017 Oct; 7(1):13534. PubMed ID: 29051564
[TBL] [Abstract][Full Text] [Related]
30. Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment.
Stankevicius V; Vasauskas G; Bulotiene D; Butkyte S; Jarmalaite S; Rotomskis R; Suziedelis K
BMC Cancer; 2016 Oct; 16(1):789. PubMed ID: 27729023
[TBL] [Abstract][Full Text] [Related]
31. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide screen for aberrantly expressed miRNAs reveals miRNA profile signature in breast cancer.
Guo L; Zhao Y; Yang S; Cai M; Wu Q; Chen F
Mol Biol Rep; 2013 Mar; 40(3):2175-86. PubMed ID: 23196705
[TBL] [Abstract][Full Text] [Related]
33. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
34. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
35. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
[TBL] [Abstract][Full Text] [Related]
36. Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress.
Triulzi T; Casalini P; Sandri M; Ratti M; Carcangiu ML; Colombo MP; Balsari A; Ménard S; Orlandi R; Tagliabue E
PLoS One; 2013; 8(2):e56761. PubMed ID: 23441215
[TBL] [Abstract][Full Text] [Related]
37. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
38. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
39. A Novel Method to Detect Functional microRNA Regulatory Modules by Bicliques Merging.
Liang C; Li Y; Luo J
IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(3):549-56. PubMed ID: 27295638
[TBL] [Abstract][Full Text] [Related]
40. miRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer cells.
Harquail J; LeBlanc N; Ouellette RJ; Robichaud GA
Carcinogenesis; 2019 Aug; 40(8):1010-1020. PubMed ID: 30605519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
